Advertisement
Scilex Holding Company

Scilex Holding Company (SCLX) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

SCLXNASDAQ
HealthcareDrug Manufacturers - General
$8.80
$1.76(25.000%)
U.S. Market opens in 16h 22m
Advertisement

Scilex Holding Company (SCLX)

Meyka AI Score

Z

Key Financials

Market Cap74.7M
P/E Ratio-0.12
EPS (TTM)$-40.50
ROE1.90%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.10
3 Months$11.45
1 Year Target$22.10

SCLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scilex Holding Company (SCLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.12 and a market capitalization of 74.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
25.00%
5-Day Change
13.40%
1-Month Change
12.53%
3-Month Change
1.73%
6-Month Change
-49.10%
Year-to-Date (YTD) Change
-27.87%
1-Year Change
45.94%
3-Year Change
-96.52%
5-Year Change
-97.47%
All-Time (Max) Change
-97.45%

Contact Information

650-516-4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

115 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions